#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic thrombocytopenic purpura Medulloblastoma recurrent Aicardi-Goutieres syndrome Vulval cancer recurrent Follicular lymphoma stage II Prostate cancer Gastrooesophageal cancer Neurotrophic keratopathy Acute on chronic liver failure Guillain-Barre syndrome Methylmalonic acidaemia Leiomyosarcoma metastatic Peripheral T-cell lymphoma unspecified Usher's syndrome Haemophilia A without inhibitors More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Basic Information Familial amyotrophic lateral sclerosis – Basic Information Pemphigoid – Basic Information Biotinidase deficiency – Basic Information Pemphigus – Treatment Cholangitis sclerosing – Diagnostics Chordoma – Treatment Pelizaeus-Merzbacher disease – Trials in Disease Castleman’s disease Myelodysplastic syndrome with excess blasts – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Water For Injections Fluoxetine Jnj-64042056 Gsk3915393 TORASEMIDE Fluconazole Lib-01 Monohydrate INF904 Dog Epithelia SODIUM BENZOATE F44/10 ARTICAINE HYDROCHLORIDE Lurasidone 68Ga-Nota-Abscint-Her2 Benfotiamine Mrna-4157 LTI-03 Indapamide Canagliflozin S230815-2 More therapies…

    Learn about Your Condition

    Gaucher's disease type I Eyelid ptosis Viral myocarditis Psoriatic arthropathy Dementia Lymphoma Biliary cancer metastatic Thyroid mass Follicular lymphoma stage III Cluster headache Endometrial cancer metastatic Mite allergy Pouchitis Biotinidase deficiency Albright's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Tamoxifen
    • Ly3484356
    • Anastrozole
    Austria Belgium Czechia Finland France Germany +10

  • Effect of denosumab versus zoledronic acid on erosion progression in patients with erosive hand osteoarthritis and osteoporosis: a randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteoporosis
    • Osteoarthritis
    Investigated Drugs:
    • Denosumab
    • Zoledronic Acid Monohydrate
    Italy

  • Effect of Metformin Hydrochloride on Inflammation and Aging Biomarkers in Pre‑diabetic Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    Investigated Drugs:
    • Metformin Hydrochloride
    Spain

  • Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Crd-4730
    Bulgaria Czechia Hungary Italy Latvia Lithuania +4

  • Phase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Romiplostim
    • Prednisolone
    Germany Hungary Spain

  • A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Sweden
Previous Page
1 … 663 664 665 666 667 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!